Relation between predicted and measured variables stratified by mode of exercise.
. | Pooled cycle and treadmill . | Cycle . | Treadmill . | p-value . | Partial eta-squared . |
---|---|---|---|---|---|
Predicted HRmax, adjusted for β-blockade; beats/mina | 136 (118 to 174) | 138 (126 to 174) | 134 (118 to 167) | 0.009** | |
VAT, % of predicted HRmax adjusted for β-blockade | 67.97 (65.86 to 70.07) | 62.74 (59.68 to 65.80) | 71.10 (68.50 to 73.71) | <0.001** | 0.131 |
Predicted HRR, adjusted for β-blockade; beats/min | 77.85 (95% CI: 75.04 to 80.66) | 77.93 (95% CI: 73.19 to 82.68) | 77.8 (95% CI: 74.24 to 81.36) | 0.965 | <0.001 |
VAT, % of predicted HRR adjusted for β-blockadea | 40.35 (9.57 to 87.93) | 30.49 (9.57 to 69.23) | 47.06 (12 to 87.93) | <0.001*** | |
Predicted VO2peak, mL·min–1 | 2272.14 (95% CI: 2184.11 to 2360.17) | 2258.79 (95% CI: 2114.05 to 2403.53) | 2280.35 (95% CI: 2166.68 to 2394.01) | 0.815 | <0.001 |
VO2peak, % of predicted VO2peak | 87.85 (95% CI: 84.11 to 91.58) | 89.99 (95% CI: 82.64 to 97.35) | 86.56 (95% CI: 82.40 to 90.72) | 0.380 | 0.007 |
. | Pooled cycle and treadmill . | Cycle . | Treadmill . | p-value . | Partial eta-squared . |
---|---|---|---|---|---|
Predicted HRmax, adjusted for β-blockade; beats/mina | 136 (118 to 174) | 138 (126 to 174) | 134 (118 to 167) | 0.009** | |
VAT, % of predicted HRmax adjusted for β-blockade | 67.97 (65.86 to 70.07) | 62.74 (59.68 to 65.80) | 71.10 (68.50 to 73.71) | <0.001** | 0.131 |
Predicted HRR, adjusted for β-blockade; beats/min | 77.85 (95% CI: 75.04 to 80.66) | 77.93 (95% CI: 73.19 to 82.68) | 77.8 (95% CI: 74.24 to 81.36) | 0.965 | <0.001 |
VAT, % of predicted HRR adjusted for β-blockadea | 40.35 (9.57 to 87.93) | 30.49 (9.57 to 69.23) | 47.06 (12 to 87.93) | <0.001*** | |
Predicted VO2peak, mL·min–1 | 2272.14 (95% CI: 2184.11 to 2360.17) | 2258.79 (95% CI: 2114.05 to 2403.53) | 2280.35 (95% CI: 2166.68 to 2394.01) | 0.815 | <0.001 |
VO2peak, % of predicted VO2peak | 87.85 (95% CI: 84.11 to 91.58) | 89.99 (95% CI: 82.64 to 97.35) | 86.56 (95% CI: 82.40 to 90.72) | 0.380 | 0.007 |
Boldface values simply mean that they are significant at the P<0.05 level.
Variables are reported as median (minimum and maximum) values and analysed using a non-parametric test.
p < 0.05
p < 0.01
p < 0.001
HRmax: maximal heart rate; VAT: ventilatory anaerobic threshold; HRR: heart rate reserve; VO2Peak, peak oxygen consumption
Relation between predicted and measured variables stratified by mode of exercise.
. | Pooled cycle and treadmill . | Cycle . | Treadmill . | p-value . | Partial eta-squared . |
---|---|---|---|---|---|
Predicted HRmax, adjusted for β-blockade; beats/mina | 136 (118 to 174) | 138 (126 to 174) | 134 (118 to 167) | 0.009** | |
VAT, % of predicted HRmax adjusted for β-blockade | 67.97 (65.86 to 70.07) | 62.74 (59.68 to 65.80) | 71.10 (68.50 to 73.71) | <0.001** | 0.131 |
Predicted HRR, adjusted for β-blockade; beats/min | 77.85 (95% CI: 75.04 to 80.66) | 77.93 (95% CI: 73.19 to 82.68) | 77.8 (95% CI: 74.24 to 81.36) | 0.965 | <0.001 |
VAT, % of predicted HRR adjusted for β-blockadea | 40.35 (9.57 to 87.93) | 30.49 (9.57 to 69.23) | 47.06 (12 to 87.93) | <0.001*** | |
Predicted VO2peak, mL·min–1 | 2272.14 (95% CI: 2184.11 to 2360.17) | 2258.79 (95% CI: 2114.05 to 2403.53) | 2280.35 (95% CI: 2166.68 to 2394.01) | 0.815 | <0.001 |
VO2peak, % of predicted VO2peak | 87.85 (95% CI: 84.11 to 91.58) | 89.99 (95% CI: 82.64 to 97.35) | 86.56 (95% CI: 82.40 to 90.72) | 0.380 | 0.007 |
. | Pooled cycle and treadmill . | Cycle . | Treadmill . | p-value . | Partial eta-squared . |
---|---|---|---|---|---|
Predicted HRmax, adjusted for β-blockade; beats/mina | 136 (118 to 174) | 138 (126 to 174) | 134 (118 to 167) | 0.009** | |
VAT, % of predicted HRmax adjusted for β-blockade | 67.97 (65.86 to 70.07) | 62.74 (59.68 to 65.80) | 71.10 (68.50 to 73.71) | <0.001** | 0.131 |
Predicted HRR, adjusted for β-blockade; beats/min | 77.85 (95% CI: 75.04 to 80.66) | 77.93 (95% CI: 73.19 to 82.68) | 77.8 (95% CI: 74.24 to 81.36) | 0.965 | <0.001 |
VAT, % of predicted HRR adjusted for β-blockadea | 40.35 (9.57 to 87.93) | 30.49 (9.57 to 69.23) | 47.06 (12 to 87.93) | <0.001*** | |
Predicted VO2peak, mL·min–1 | 2272.14 (95% CI: 2184.11 to 2360.17) | 2258.79 (95% CI: 2114.05 to 2403.53) | 2280.35 (95% CI: 2166.68 to 2394.01) | 0.815 | <0.001 |
VO2peak, % of predicted VO2peak | 87.85 (95% CI: 84.11 to 91.58) | 89.99 (95% CI: 82.64 to 97.35) | 86.56 (95% CI: 82.40 to 90.72) | 0.380 | 0.007 |
Boldface values simply mean that they are significant at the P<0.05 level.
Variables are reported as median (minimum and maximum) values and analysed using a non-parametric test.
p < 0.05
p < 0.01
p < 0.001
HRmax: maximal heart rate; VAT: ventilatory anaerobic threshold; HRR: heart rate reserve; VO2Peak, peak oxygen consumption
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.